SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-097680
Filing Date
2023-12-21
Accepted
2023-12-21 16:05:36
Documents
12
Period of Report
2023-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190499-8k_chinapharma.htm   iXBRL 8-K 25178
  Complete submission text file 0001213900-23-097680.txt   200716

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cphi-20231215.xsd EX-101.SCH 3048
3 XBRL LABEL FILE cphi-20231215_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cphi-20231215_pre.xml EX-101.PRE 22381
6 EXTRACTED XBRL INSTANCE DOCUMENT ea190499-8k_chinapharma_htm.xml XML 3395
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 231505328
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)